Pacific Biosciences Announces Launch of Certified Service Provider Program for Single Molecule, Real-Time Sequencing; Adds New Informatics Partners
Monday, March 23, 2015
The PacBio CSP program is a global network of validated service organizations utilizing PacBio’s sequencing technology. PacBio CSPs undergo a standardized certification procedure in order to ensure they are capable of delivering the highest-quality data to their clients.
The first service providers to be certified are:
DNA Link, Inc., based in
GATC Biotech AG, based in Germany
Takara Bio Inc., based in
Arizona Genomics Institute, University of Arizona, Tucson
“We have seen great demand for SMRT Sequencing in
To support increased demand for analysis and interpretation of SMRT Sequencing data, Pacific Biosciences has added three new informatics partners:
DNAnexus, Inc., facilitates cloud-based genome informatics and data management, with optimization for de novo assembly of large genomes with SMRT Sequencing data
Biosoft Integrators, Inc., delivers High Performance Computational solutions with pre-installed SMRT Analysis software to give PacBio users a seamless experience on a local compute environment
Computomics provides PacBio users with extensive expertise in de novo assembly, the Iso-Seq™ method, and gene annotation for plant genomics projects
“Pacific Biosciences has been a pioneer and leader in long-read sequencing technology and applications,” said
Sequencing service providers interested in learning more about the CSP program can visit: www.pacb.com/SMRTproviders.
Third-party vendors interested in learning more about PacBio’s Partner program can visit:
About Pacific Biosciences
in combination with the ability to detect real-time kinetic information. The PacBio RS II System, including consumables and software provides a simple, fast, end-to-end workflow for SMRT Sequencing. More information is available at www.pacb.com.
Forward Looking Statements
All statements in this press release that are not historical are forward-looking statements, including, among other things, statements relating to future uses and performance of the Company’s products and other future events. You should not place undue reliance on forward-looking statements because they involve known and unknown risks, uncertainties and other factors that are, in some cases, beyond the Company’s control and could materially affect actual results. Factors that could materially affect actual results can be found in our most recent filings with the
CONTACT: For Pacific Biosciences: Media:
Nicole Litchfield415.793.6468 email@example.com Investors: Trevin Rard650.521.8450 firstname.lastname@example.org
News Provided by Acquire Media